Tag: Manufacturing
3D GEM 2025: IISc Bengaluru to host India’s Premier 3D Engineering...
Serving as a pan-sector platform, it will showcase 3D solutions in engineering, industrial manufacturing, aerospace, energy, medical, dental, and research domains
Eli Lilly expands operations in India, to invest $1 Billion for...
Investment to expand manufacturing and global medicine supply capacity — resonating with the Make in India agenda
Aragen appoints Aniel Khubchandani as CEO of Development & Manufacturing Solutions...
Aniel will be a member of Aragen’s Management Council and will be based in Hyderabad
Miltenyi Biotec and THSTI partner to launch India’s first hands-on CAR-T...
This groundbreaking collaboration aims to bridge India’s talent and translational gap in this rapidly growing field by equipping professionals with practical expertise in the manufacturing of advanced therapies
Loopworm raises $3.25M Pre-Series A to commercialize breakthrough recombinant protein production...
Advanced silkworm bio-factory set to disrupt protein production systems through its novel technology
Lupin and SteinCares enter into license & supply agreement for Ranibizumab...
SteinCares will handle all regulatory filings, registrations and commercialization of Ranibizumab in LATAM, while Lupin will be responsible for manufacturing the same
BioVoice eMagazine May 2025 | Issue 5 | Volume 6
The Cover Story analyses the potential impact of significant uncertainty due to the proposed reciprocal tariffs with insights from Vishal Dhikale, Associate Vice President, Avalon Consulting. Read interview of Puneeth Kumar KT, Business Director for Planetary Health Biosolutions, Novonesis South Asia and Expert Insights by Mahesh Ramanujam, President & CEO, Global Network for Zero; and Dr Vidhi Bhanushali, CEO and Co-founder, scanO.
India highlights its BioE3 policy & Integrated Biorefinery Initiatives at Mission...
The participants highlighted how the BioE3 Policy promotes sustainable and low-carbon manufacturing of fuels, chemicals, and materials
Syngene concludes acquisition of biologics manufacturing facility from Emergent BioSolutions
The new site will increase Syngene's total single-use bioreactor capacity to 50,000L for large molecule discovery, development, and manufacturing services
BioVoice eMagazine March 2025 | Issue 3 | Volume 6
The Cover Story tracks the surge in the big-ticket investments by MNCs to spearhead the next wave of innovation. Read interview of Shailendra Vyas CEO and Director, Bioheaven360 Genotec. Expert Insights by Shereef Rehuman, MD, ICEXPO Consults and Daara Patel, Secretary General, IDMA; and Ninad Karandikar, Co-founder, Stance Health